NK1.1+ Cells and IL-22 Regulate Vaccine-Induced Protective Immunity against Challenge with Mycobacterium tuberculosis
- 15 July 2012
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 189 (2) , 897-905
Abstract
We previously found that human NK cells lyse Mycobacterium tuberculosis-infected monocytes and alveolar macrophages and upregulate CD8+ T cell responses. We also found that human NK cells produce IL-22, which inhibits intracellular growth of M. tuberculosis, and that NK cells lyse M. tuberculosis-expanded CD4+CD25+FOXP3+ T regulatory cells (Tregs). To determine the role of NK cells during the protective immune response to vaccination in vivo, we studied the NK cell and T cell responses in a mouse model of vaccination with bacillus Calmette-Guérin (BCG), followed by challenge with virulent M. tuberculosis H37Rv. BCG vaccination enhanced the number of IFN-γ–producing and IL-22–producing NK cells. Depletion of NK1.1+ cells at the time of BCG vaccination increased the number of immunosuppressive Tregs (CD4+CD25hi, 95% Foxp3+) after challenge with M. tuberculosis H37Rv, and NK1.1+ cells lysed expanded but not natural Tregs in BCG-vaccinated mice. Depletion of NK1.1+ cells at the time of BCG vaccination also increased the bacillary burden and reduced T cell responses after challenge with M. tuberculosis H37Rv. IL-22 at the time of vaccination reversed these effects and enhanced Ag-specific CD4+ cell responses in BCG-vaccinated mice after challenge with M. tuberculosis H37Rv. Our study provides evidence that NK1.1+ cells and IL-22 contribute to the efficacy of vaccination against microbial challenge.Keywords
This publication has 102 references indexed in Scilit:
- Interleukin-22 Is Produced by Invariant Natural Killer T Lymphocytes during Influenza A Virus InfectionJournal of Biological Chemistry, 2012
- Predominance of interleukin-22 over interleukin-17 at the site of disease in human tuberculosisTuberculosis, 2011
- Role of dendritic cells in the induction of regulatory T cellsCell & Bioscience, 2011
- α-Galactosylceramide as a Therapeutic Agent for Pulmonary Mycobacterium tuberculosis InfectionAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosisJournal of Experimental Medicine, 2010
- Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH17 cytokine interleukin-22Blood, 2009
- The kinetics of CD4+Foxp3+ T cell accumulation during a human cutaneous antigen-specific memory response in vivoJournal of Clinical Investigation, 2008
- In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccinationProceedings of the National Academy of Sciences, 2008
- The Biological Functions of T Helper 17 Cell Effector Cytokines in InflammationImmunity, 2008
- Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivoJournal of Clinical Investigation, 2006